No abstract

The supercapacitive behavior of the metallic cobalt recycled from Li-ion batteries has been studied in this work. The reversibility of both redox process (Co II /Co III ) and (Co III /Co IV ) in KOH 6 mol L -1 is very high and promising for capacitive applications in electrochemical devices. The specific capacitances calculated from cyclic voltammetry and electrochemical impedance spectroscopy show a good agreement, giving the value of 625 Fg -1 . The electrode morphology presents a high porosity, thus an electrical equivalent circuit composed of two parallel resistance and capacitance elements in series was proposed. The specific capacitance values calculated from charge/discharge curves at 0.23 and 2.3 mA/cm 2 are 601 and 384 Fg -1 , respectively. Thereby, it was observed that metallic cobalt recycled from ion-Li batteries is compatible with other supercapacitive materials. This shows that cobalt recycling from Li-ion batteries is economically and environmentally viable for application in supercapacitor devices.

The combination of magnetic hyperthermia therapy with the controlled release of chemotherapeutic agents in tumors may be an efficient therapeutic with few side effects because the bioavailability, tolerance and amount of the drug can be optimized. Here, we prepared magnetoliposomes consisting of magnetite nanoparticle cores and the anticancer drug gemcitabine encapsulated by a phospholipid bilayer. The potential of these magnetoliposomes for controlled drug release and cancer treatment via hyperthermic behavior was investigated. The magnetic nanoparticle encapsulation efficiency was dependent on the initial amount of magnetite nanoparticles present at the encapsulation stage; the best formulation was 66%. We chose this formulation to characterize the physicochemical properties of the magnetoliposomes and to encapsulate gemcitabine. The mean particle size and distribution were determined by dynamic light scattering (DLS), and the zeta potential was measured. The magnetoliposome formulations all had acceptable characteristics for systemic administration, with a mean size of approximately 150 nm and a polydispersity index <0.2. The magnetoliposomes were stable in aqueous suspension for at least one week, as determined by DLS. Temperature increases due to the dissipation energy of magnetoliposome suspensions subjected to an applied alternating magnetic field (AMF) were measured at different magnetic field intensities, and the values were appropriated for cancer treatments. The drug release profile at 37 °C showed that 17% of the gemcitabine was released after 72 h. Drug release from magnetoliposomes exposed to an AMF for 5 min reached 70%.

a b s t r a c tThe delivery of the tetracycline and hydrocortisone drugs that have been incorporated into bioactive glasses was studied in this work. The potentiality of these systems in direct pulp capping is also discussed. A bioactive glass with a composition of (SiO 2 ) 0.80 (P 2 O 5 ) 0.04 (CaO) 0.16 , was prepared by sol-gel. Sols were prepared with the addition of approximately 2 wt% of tetracycline or hydrocortisone separately for the delivery studies. A third set of samples of bioglass sols containing 2 wt% of each drug were prepared with the same purpose. The amounts of drugs delivered were monitored by ultraviolet spectrophotometry in the tetracycline and hydrocortisone wavelengths. The drug release behavior was strongly dependent on the system. The glass-tetracycline samples showed a rapid drug release kinetics, while glasshydrocortisone samples show much slow release profiles. The different drug release behaviors have been explained by faster gel formation reaction between hydrocortisone and TEOS due to a stronger interaction between these reagents. On the samples with both drugs, the release was simultaneous and for each drug, the amounts delivered followed a profile similar to the samples with only this specific drug.

No abstract